Online weight loss treatment in Rhode Island
Surfbound connects eligible adults in Rhode Island with licensed providers for online GLP-1 weight-loss treatment review. Semaglutide $169/mo and tirzepatide $219/mo. Prescriptions are not guaranteed and are issued only when medically appropriate.
No in-person visit. A licensed provider reviews your intake. A prescription is not guaranteed.
Can I start online GLP-1 weight loss treatment in Rhode Island?
Yes. Eligible adults across Rhode Island can begin an online GLP-1 weight-loss evaluation with Surfbound without an in-person visit. A licensed provider credentialed in Rhode Island reviews your health intake and, if treatment is medically appropriate, your prescription may be sent to a licensed pharmacy and shipped discreetly to your Rhode Island address. Semaglutide is $169/mo and tirzepatide is $219/mo; a prescription is never guaranteed.
The Ocean State · Northeast region. A compact state with strong telehealth parity. Quick online access across a compact state.
Cities in Rhode Island
Coverage across Rhode Island
Surfbound lists 1 Rhode Island cities with a dedicated local page. Care is delivered online, so you can also start from anywhere else in the state.
Provider access & processPricing and insurance
Semaglutide is $169/mo and tirzepatide is $219/mo. Clear pricing shown before checkout. Surfbound does not accept insurance at this time.
Shipping to Rhode Island
After provider approval, a licensed compounding pharmacy prepares and dispatches the order. For Rhode Island addresses, from Providence, Warwick, Cranston to smaller communities, transit time depends on distance from the dispensing pharmacy, the pharmacy's processing day, weekends and carrier volume — tracking is emailed once the package is with the carrier.
What's included in every Rhode Island plan
One flat monthly price covers the licensed provider review, medication if prescribed, and discreet shipping. There is no separate membership fee.
Rhode Island coverage & access
Practical answers about where you can start, how shipping works, and how to compare complete costs in Rhode Island. The Rhode Island provider access & process page covers the clinical steps in detail.
Surfbound lists 1 Rhode Island cities with a dedicated local page. Because care is delivered online, you can start from anywhere in Rhode Island — the city list is a navigation aid, not a limit on where you can begin.
The Rhode Island telehealth page explains how the online provider review works, what to prepare before your review, and how prescriptions and provider switches are handled. This coverage page links to it so you have one process reference and one coverage reference.
No. Surfbound is an online service with no physical offices in Rhode Island. You complete a health intake online, and a licensed provider credentialed in Rhode Island reviews your information remotely.
Rhode Island permits telehealth review and prescribing when a proper provider-patient relationship is established, which the online intake and review process does. A provider licensed in Rhode Island may review a Rhode Island patient remotely and prescribe only when treatment is medically appropriate. The licensing board, the telehealth statute or rule, and the licensure requirement are listed in the “Telehealth rules in Rhode Island” section on this page.
Check the two credentials separately. The reviewing clinician must hold an active Rhode Island license issued by the Rhode Island Board of Medical Licensure and Discipline, and any pharmacy filling your prescription must be licensed in Rhode Island. Both are public lookups — the board and the telehealth statute or rule that govern them are linked in the “Telehealth rules in Rhode Island” section on this page.
Rhode Island residents pay $169/mo for compounded semaglutide or $219/mo for compounded tirzepatide, provider review included. Compounded medications are not FDA-approved, and the price is displayed before you pay.
If a provider determines treatment is medically appropriate, a prescription may be sent to a licensed compounding pharmacy and medication ships discreetly. Shipping is included; timing depends on pharmacy processing, your location, weekends, and holidays, and tracking is provided.
No. A prescription for a Rhode Island patient is issued only when a licensed Rhode Island provider determines treatment is medically appropriate after reviewing the health intake.
Yes. Rhode Island patients already taking a GLP-1 can request a dose match when clinically appropriate. Sign up and use the doctor-notes field at the end of the form to list your current medication and dose, and whether you want to stay at that dose or discuss increasing it. Your Rhode Island-licensed clinician reviews the request and determines the prescription. No written quote is required to switch.
For Rhode Island patients, the honest comparison is all-in monthly cost at the same dose. The GLP-1 total-cost calculator normalises membership, shipping and titration fees against one flat published rate.
Compounded semaglutide is one of the two GLP-1 options available across Rhode Island, priced flat each month with the provider review included. Nothing ships unless a Rhode Island-licensed provider approves treatment. It is not an FDA-approved medication.
Compounded tirzepatide is part of the Rhode Island offering, priced flat each month with delivery included. Whether it is the right option is a clinical decision made by a Rhode Island-licensed provider, and it is not an FDA-approved medication.
Yes. Oral semaglutide and oral tirzepatide are listed options alongside the compounded injectables, and Rhode Island residents are reviewed the same way for either route. Whether an oral option is appropriate is decided by the Rhode Island-licensed provider during your review, and oral pricing is shown on those product pages.
No insurer's approval is required to start in Rhode Island. Surfbound is cash-pay: semaglutide is $169/mo and tirzepatide is $219/mo, the provider review is included, and there is no separate membership fee. Nothing is charged unless a licensed Rhode Island provider approves your medication. A compact state with strong telehealth parity.
Yes. Rhode Island residents priced out of a brand-name GLP-1 can be reviewed for compounded semaglutide or tirzepatide. A licensed Rhode Island provider decides what may be appropriate, and one flat monthly price applies with no dose-based upcharge. Compounded medications are not FDA-approved versions of Wegovy or Zepbound.
Many people across Rhode Island with PCOS, insulin resistance, or prediabetes explore compounded GLP-1 treatment because brand-name coverage for these uses is often denied. A Rhode Island-licensed provider reviews your full history to decide whether treatment is medically appropriate. Compounded medications are not FDA-approved.
Yes. Rhode Island residents complete a short online intake on their own schedule, and a Rhode Island-licensed provider reviews it remotely. If prescribed, medication ships to your door — no clinic, waiting room, or daytime appointment. A compact state with strong telehealth parity. Quick online access across a compact state.
Yes. Men across Rhode Island begin with a private online intake, a licensed Rhode Island provider reviews their history remotely, and if prescribed, medication ships in plain, discreet packaging. There is no waiting room, no in-person visit, and no pharmacy-counter pickup.
Yes. Surfbound support reaches Rhode Island residents by text/SMS, email (hello@surfbound.co), and phone — new patients at (941) 315-5217 (Monday–Friday, 9:00 AM–5:00 PM ET) and existing patients at (813) 532-3185 (Monday–Friday, 9:00 AM–5:00 PM MST). You can ask about your plan, dosing, or shipping without booking another appointment.
Telehealth rules in Rhode Island
What governs a provider treating a Rhode Island patient online, and where you can check it yourself.
State medical board
Rhode Island Board of Medical Licensure and DisciplineRhode Island Board of Medical Licensure and Discipline licenses the providers who review Rhode Island intakes. The board site carries the current licensing and practice requirements.
Telehealth statute or rule
Rhode Island General Laws Title 5, Chapter 37Opens the official Rhode Island code. Search the statute or rule named above for the full text rather than relying on any summary.
Licensure requirement
A clinician must hold an active Rhode Island license to evaluate or treat a patient who is physically located in Rhode Island. Every Rhode Island intake is routed to a provider credentialed in Rhode Island, and a prescription is issued only when that provider determines treatment is medically appropriate.
Rhode Island permits telemedicine prescribing when a proper provider-patient relationship has been established. The state has telehealth parity laws ensuring remote care is treated equivalently to in-person care for coverage purposes.
Surfbound is an online service. We do not have physical offices in Rhode Island. Licensed providers review health information online. A prescription is not guaranteed.
Medical sources & references
Surfbound providers are licensed to practice in Rhode Island and follow applicable state medical board rules for telehealth. The following authoritative sources inform our treatment information.
Official Rhode Island state government agency. Provider licensure in Rhode Island is governed by the Rhode Island Board of Medical Licensure and Discipline.
- FDA — Human Drug CompoundingFDA guidance clarifying that compounded medications are not FDA-approved.
- FDA — Compounding: Questions and AnswersConfirms compounded drugs are not reviewed by FDA for safety or effectiveness.
- NIDDK (NIH) — Prescription Medications to Treat Overweight & ObesityNIH guidance on GLP-1 receptor agonists for medical weight management.
- CDC — Adult Obesity FactsNational adult obesity prevalence data referenced for regional context.
- ASMBS — American Society for Metabolic and Bariatric SurgeryProfessional guidance on metabolic and bariatric medicine.
- MedlinePlus (NIH) — Weight ControlConsumer health information on weight management from the National Library of Medicine.
A prescription is not guaranteed and is issued only when a licensed provider determines treatment is medically appropriate.